Biotest Aktiengesellschaft (BIO3) — Capital Reinvestment Ratio
Biotest Aktiengesellschaft (BIO3) has a Capital Reinvestment Ratio of 0.50x as of December 2023, meaning it reinvests 0% of its operating cash flow (€67.40 Million) in capital expenditures (€33.40 Million). See Biotest Aktiengesellschaft balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Biotest Aktiengesellschaft Capital Reinvestment Ratio (2002–2024)
This chart tracks Biotest Aktiengesellschaft's Capital Reinvestment Ratio across 13 annual periods. Check BIO3 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Biotest Aktiengesellschaft (2002–2024)
Year-by-year Capital Reinvestment Ratio for Biotest Aktiengesellschaft from 2002 to 2024. For live market cap and broader valuation context, see market value of Biotest Aktiengesellschaft.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.47x | €60.90 Million | €28.70 Million | ▼ -12.2% |
| 2021 | 0.54x | €33.90 Million | €18.20 Million | ▼ -82.7% |
| 2017 | 3.10x | €34.30 Million | €106.50 Million | ▲ +42.2% |
| 2016 | 2.18x | €65.90 Million | €143.90 Million | ▼ -17.4% |
| 2015 | 2.64x | €38.10 Million | €100.70 Million | ▲ +166.0% |
| 2012 | 0.99x | €34.73 Million | €34.51 Million | ▲ +168.8% |
| 2011 | 0.37x | €72.28 Million | €26.72 Million | ▼ -2.1% |
| 2010 | 0.38x | €77.83 Million | €29.37 Million | ▼ -70.2% |
| 2009 | 1.27x | €31.68 Million | €40.17 Million | ▲ +19.7% |
| 2008 | 1.06x | €34.49 Million | €36.54 Million | ▲ +43.9% |
| 2004 | 0.74x | €25.29 Million | €18.62 Million | ▼ -40.7% |
| 2003 | 1.24x | €16.52 Million | €20.51 Million | ▼ -90.1% |
| 2002 | 12.52x | €2.46 Million | €30.80 Million | — |